BridgeBio Pharma (BBIO) Gross Margin (2020 - 2026)
BridgeBio Pharma (BBIO) recorded Gross Margin of 93.83% in Q2 2026, down 2.87 percentage points from 96.70% a year earlier and down 1.06 percentage points from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Gross Margin (2020 - 2026) Analysis & Trends
On a TTM basis, BridgeBio Pharma's Gross Margin came in at 94.44% as of Jun 30, 2026, down 1.76 percentage points year-over-year; for FY2025, it was 95.82%, down 2.43 percentage points from FY2024.
- Annual Gross Margin has a five-year change of -4.18 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 98.25% in FY2024 (+24.54 pp), 73.71% in FY2023 (-21.87 pp), 95.58% in FY2022 (+0.04 pp) and 95.53% in FY2021 (-4.47 pp).
- The Q2 2026 figure is the lowest quarterly Gross Margin since Q4 2024.
- On a year-over-year basis, Gross Margin rose in three of the last eight quarters, with an average year-over-year change of +6.85 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 204.02 percentage points in Q3 2023, against a drop of 156.61 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 94.89% (Q1 2026), 94.74% (Q4 2025) and 94.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | BridgeBio Pharma | 13.01 Bn | 10.12 Bn | 228.63 Mn | 93.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.83% |
| Mar 31, 2026 | 94.89% |
| Dec 31, 2025 | 94.74% |
| Sep 30, 2025 | 94.56% |
| Jun 30, 2025 | 96.70% |
| Mar 31, 2025 | 97.74% |
| Dec 31, 2024 | 64.57% |
| Sep 30, 2024 | 78.11% |
| Jun 30, 2024 | 72.42% |
| Mar 31, 2024 | 99.72% |
| Dec 31, 2023 | 65.73% |
| Sep 30, 2023 | 85.38% |
| Jun 30, 2023 | 63.50% |
| Mar 31, 2023 | 64.35% |
| Dec 31, 2022 | 65.40% |
| Sep 30, 2022 | -118.64% |
| Jun 30, 2022 | 99.05% |
| Mar 31, 2022 | 20.43% |
| Dec 31, 2021 | 87.96% |
| Sep 30, 2021 | 37.97% |
API Access
BridgeBio Pharma Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();